Berner K, Hernes E, Kvassheim M, Revheim ME, Bastiansen J, Selboe S, Bakken CL, Grønningsæter SR, Bruland ØS, Larsen RH, Bouzelmat L, Jardine VL, Stokke C (2025)
First-in-Human Phase 0 Study of AB001, a Prostate-Specific Membrane Antigen-Targeted ²¹²Pb Radioligand, in Patients with Metastatic Castration-Resistant Prostate Cancer
J Nucl Med, 66 (5), 732-738
DOI 10.2967/jnumed.124.269299, PubMed 40081958

Fauske L, Bruland Ø, Hompland I (2025)
Addressing and supporting the unmet needs of sarcoma survivors: a qualitative study
Int J Qual Stud Health Well-being, 20 (1), 2597584
DOI 10.1080/17482631.2025.2597584, PubMed 41382317

Høyvik AJK, Kvassheim M, Ma LW, Wiig E, Hillestad T, Revheim ME, Liukaityte R, Bruland Ø, Juzeniene A (2025)
Therapeutic evaluation of [²¹²Pb]Pb-AB001 and [¹⁷⁷Lu]Lu-PSMA-617 in a mouse model of disseminated prostate cancer
Eur J Nucl Med Mol Imaging, 52 (13), 4847-4859
DOI 10.1007/s00259-025-07330-y, PubMed 40397137